Abnormal 0 8 0 8 O
cardiac 9 16 9 16 B-clinical_variable
valve 17 22 17 22 I-clinical_variable
morphology 23 33 23 33 I-clinical_variable
( 34 35 34 35 O
≥grade 35 41 35 41 O
2 42 43 42 43 I-lower_bound
) 43 44 43 44 O
documented 45 55 45 55 O
by 56 58 56 58 O
echocardiogram 59 73 59 73 B-treatment

All 0 3 74 77 O
prior 4 9 78 83 B-treatment
anti 10 14 84 88 I-treatment
- 14 15 88 89 I-treatment
cancer 15 21 89 95 I-treatment
treatment 22 31 96 105 I-treatment
- 31 32 105 106 O
related 32 39 106 113 O
toxicities 40 50 114 124 O
( 51 52 125 126 O
except 52 58 126 132 O
alopecia 59 67 133 141 B-chronic_disease
and 68 71 142 145 O
laboratory 72 82 146 156 O
values 83 89 157 163 O
as 90 92 164 166 O
listed 93 99 167 173 O
in 100 102 174 176 O
Eligibility 103 114 177 188 O
Criteria 115 123 189 197 O
# 124 125 198 199 O
4 125 126 199 200 O
) 126 127 200 201 O
must 128 132 202 206 O
be 133 135 207 209 O
Grade 136 141 210 215 O
1 142 143 216 217 O
according 144 153 218 227 O
to 154 156 228 230 O
the 157 160 231 234 O
Common 161 167 235 241 O
Terminology 168 179 242 253 O
Criteria 180 188 254 262 O
for 189 192 263 266 O
Adverse 193 200 267 274 O
Events 201 207 275 281 O
version 208 215 282 289 O
4 216 217 290 291 O
( 218 219 292 293 O
CTCAE 219 224 293 298 O
version 225 232 299 306 O
4.03 233 237 307 311 O
, 237 238 311 312 O
2009 239 243 313 317 O
) 243 244 317 318 O
at 245 247 319 321 O
the 248 251 322 325 O
time 252 256 326 330 O
of 257 259 331 333 O
starting 260 268 334 342 O
treatment 269 278 343 352 O

Any 0 3 353 356 O
number 4 10 357 363 O
and 11 14 364 367 O
type 15 19 368 372 O
of 20 22 373 375 O
prior 23 28 376 381 O
anticancer 29 39 382 392 B-treatment
therapies 40 49 393 402 I-treatment

BRAF 0 4 403 407 B-treatment
or 5 7 408 410 O
MEK 8 11 411 414 B-treatment
inhibitors 12 22 415 425 I-treatment

Current 0 7 426 433 O
use 8 11 434 437 O
of 12 14 438 440 O
a 15 16 441 442 O
prohibited 17 27 443 453 O
medication 28 38 454 464 O
as 39 41 465 467 O
described 42 51 468 477 O
in 52 54 478 480 O
Section 55 62 481 488 O
6.3.8 63 68 489 494 O
of 69 71 495 497 O
the 72 75 498 501 O
protocol 76 84 502 510 O
for 85 88 511 514 O
Potential 89 98 515 524 O
for 99 102 525 528 O
Drug 103 107 529 533 O
- 107 108 533 534 O
Drug 108 112 534 538 O
Interaction 113 124 539 550 O
: 124 125 550 551 O
apply 126 131 552 557 O
moisturizing 132 144 558 570 O
creams 145 151 571 577 O
frequently 152 162 578 588 O
, 162 163 588 589 O
topical 164 171 590 597 B-treatment
keratolytics 172 184 598 610 I-treatment
( 185 186 611 612 O
e.g. 186 190 612 616 O
urea 191 195 617 621 B-clinical_variable
20 196 198 622 624 B-lower_bound
- 198 199 624 625 O
40 199 201 625 627 B-upper_bound
% 202 203 628 629 I-upper_bound
cream 204 209 630 635 O
, 209 210 635 636 O
salicylic 211 220 637 646 B-clinical_variable
acid 221 225 647 651 I-clinical_variable
6 226 227 652 653 O
% 227 228 653 654 O
, 228 229 654 655 O
tazarotene 230 240 656 666 B-clinical_variable
0.1 241 244 667 670 O
% 244 245 670 671 O
cream 246 251 672 677 O
, 251 252 677 678 O
fluorouracil 253 265 679 691 B-clinical_variable
5 266 267 692 693 O
% 267 268 693 694 O
cream 269 274 695 700 O
) 274 275 700 701 O
, 275 276 701 702 O
clobetasol 277 287 703 713 B-treatment
propionate 288 298 714 724 I-treatment
0.05 299 303 725 729 O
% 303 304 729 730 O
ointment 305 313 731 739 B-treatment
for 314 317 740 743 O
erythematous 318 330 744 756 O
areas 331 336 757 762 O
, 336 337 762 763 O
topical 338 345 764 771 B-treatment
lidocaine 346 355 772 781 I-treatment
2 356 357 782 783 O
% 357 358 783 784 O
, 358 359 784 785 O
and 360 363 786 789 O
/ 364 365 790 791 O
or 366 368 792 794 O
systemic 369 377 795 803 O
pain 378 382 804 808 B-treatment
medication 383 393 809 819 I-treatment
such 394 398 820 824 O
as 399 401 825 827 O
nonsteroidal 402 414 828 840 B-treatment
anti 415 419 841 845 I-treatment
- 419 420 845 846 I-treatment
inflammatory 420 432 846 858 I-treatment
drugs 433 438 859 864 I-treatment
, 438 439 864 865 O
codeine 440 447 866 873 B-treatment
, 447 448 873 874 O
and 449 452 875 878 O
pregabalin 453 463 879 889 B-treatment
for 464 467 890 893 O
pain 468 472 894 898 O

Current 0 7 899 906 O
≥ 8 9 907 908 O
Class 10 15 909 914 B-lower_bound
II 16 18 915 917 I-lower_bound
congestive 19 29 918 928 B-chronic_disease
heart 30 35 929 934 I-chronic_disease
failure 36 43 935 942 I-chronic_disease
as 44 46 943 945 O
defined 47 54 946 953 O
by 55 57 954 956 O
New 58 61 957 960 B-clinical_variable
York 62 66 961 965 I-clinical_variable
Heart 67 72 966 971 I-clinical_variable
Association 73 84 972 983 I-clinical_variable

Due 0 3 984 987 O
to 4 6 988 990 O
risk 7 11 991 995 O
of 12 14 996 998 O
disease 15 22 999 1006 O
exacerbation 23 35 1007 1019 O
patients 36 44 1020 1028 O
with 45 49 1029 1033 O
porphyria 50 59 1034 1043 B-chronic_disease
or 60 62 1044 1046 O
psoriasis 63 72 1047 1056 B-chronic_disease
are 73 76 1057 1060 O
ineligible 77 87 1061 1071 O
unless 88 94 1072 1078 O
the 95 98 1079 1082 O
disease 99 106 1083 1090 O
is 107 109 1091 1093 O
well 110 114 1094 1098 O
controlled 115 125 1099 1109 O
and 126 129 1110 1113 O
they 130 134 1114 1118 O
are 135 138 1119 1122 O
under 139 144 1123 1128 O
the 145 148 1129 1132 O
care 149 153 1133 1137 O
of 154 156 1138 1140 O
a 157 158 1141 1142 O
specialist 159 169 1143 1153 O
for 170 173 1154 1157 O
the 174 177 1158 1161 O
disorder 178 186 1162 1170 O
who 187 190 1171 1174 O
agrees 191 197 1175 1181 O
to 198 200 1182 1184 O
monitor 201 208 1185 1192 O
the 209 212 1193 1196 O
patient 213 220 1197 1204 O
for 221 224 1205 1208 O
exacerbations 225 238 1209 1222 O

Have 0 4 1223 1227 O
a 5 6 1228 1229 O
known 7 12 1230 1235 O
immediate 13 22 1236 1245 O
or 23 25 1246 1248 O
delayed 26 33 1249 1256 O
hypersensitivity 34 50 1257 1273 O
reaction 51 59 1274 1282 O
or 60 62 1283 1285 O
idiosyncrasy 63 75 1286 1298 O
to 76 78 1299 1301 O
drugs 79 84 1302 1307 O
chemically 85 95 1308 1318 O
related 96 103 1319 1326 O
to 104 106 1327 1329 O
study 107 112 1330 1335 B-treatment
drug 113 117 1336 1340 I-treatment
, 117 118 1340 1341 O
or 119 121 1342 1344 O
excipients 122 132 1345 1355 O
or 133 135 1356 1358 O
to 136 138 1359 1361 O
dimethyl 139 147 1362 1370 B-allergy_name
sulfoxide 148 157 1371 1380 I-allergy_name
( 158 159 1381 1382 I-allergy_name
DMSO 159 163 1382 1386 I-allergy_name
) 163 164 1386 1387 I-allergy_name

History 0 7 1388 1395 O
of 8 10 1396 1398 O
acute 11 16 1399 1404 B-chronic_disease
coronary 17 25 1405 1413 I-chronic_disease
syndromes 26 35 1414 1423 I-chronic_disease
( 36 37 1424 1425 O
including 37 46 1425 1434 O
myocardial 47 57 1435 1445 B-chronic_disease
infarction 58 68 1446 1456 I-chronic_disease
and 69 72 1457 1460 O
unstable 73 81 1461 1469 B-chronic_disease
angina 82 88 1470 1476 I-chronic_disease
) 88 89 1476 1477 O
, 89 90 1477 1478 O
coronary 91 99 1479 1487 B-treatment
angioplasty 100 111 1488 1499 I-treatment
, 111 112 1499 1500 O
or 113 115 1501 1503 O
stenting 116 124 1504 1512 B-treatment
within 125 131 1513 1519 O
6 132 133 1520 1521 B-upper_bound
months 134 140 1522 1528 I-upper_bound
prior 141 146 1529 1534 I-upper_bound
to 147 149 1535 1537 O
randomization 150 163 1538 1551 O

History 0 7 1552 1559 O
of 8 10 1560 1562 O
interstitial 11 23 1563 1575 B-chronic_disease
lung 24 28 1576 1580 I-chronic_disease
disease 29 36 1581 1588 I-chronic_disease
or 37 39 1589 1591 O
chronic 40 47 1592 1599 O
pneumonitis 48 59 1600 1611 B-chronic_disease

History 0 7 1612 1619 O
of 8 10 1620 1622 O
malignancy 11 21 1623 1633 B-cancer
other 22 27 1634 1639 O
than 28 32 1640 1644 O
disease 33 40 1645 1652 O
under 41 46 1653 1658 O
study 47 52 1659 1664 O
within 53 59 1665 1671 O
3 60 61 1672 1673 B-upper_bound
years 62 67 1674 1679 I-upper_bound
of 68 70 1680 1682 O
study 71 76 1683 1688 O
enrollment 77 87 1689 1699 O

History 0 7 1700 1707 O
of 8 10 1708 1710 O
malignancy 11 21 1711 1721 B-cancer
with 22 26 1722 1726 O
confirmed 27 36 1727 1736 O
activating 37 47 1737 1747 O
RAS 48 51 1748 1751 O
mutation 52 60 1752 1760 O
at 61 63 1761 1763 O
any 64 67 1764 1767 O
time 68 72 1768 1772 O

Known 0 5 1773 1778 O
Hepatitis 6 15 1779 1788 B-chronic_disease
B 16 17 1789 1790 I-chronic_disease
Virus 18 23 1791 1796 I-chronic_disease
( 24 25 1797 1798 I-chronic_disease
HBV 25 28 1798 1801 I-chronic_disease
) 28 29 1801 1802 I-chronic_disease
, 29 30 1802 1803 O
or 31 33 1804 1806 O
Hepatitis 34 43 1807 1816 B-chronic_disease
C 44 45 1817 1818 I-chronic_disease
Virus 46 51 1819 1824 I-chronic_disease
( 52 53 1825 1826 I-chronic_disease
HCV 53 56 1826 1829 I-chronic_disease
) 56 57 1829 1830 I-chronic_disease
infection 58 67 1831 1840 I-chronic_disease

Negative 0 8 1841 1849 O
serum 9 14 1850 1855 O
pregnancy 15 24 1856 1865 B-pregnancy
test 25 29 1866 1870 O
within 30 36 1871 1877 O
7 37 38 1878 1879 B-upper_bound
days 39 43 1880 1884 I-upper_bound
prior 44 49 1885 1890 I-upper_bound
to 50 52 1891 1893 O
commencement 53 65 1894 1906 O
of 66 68 1907 1909 O
dosing 69 75 1910 1916 O
in 76 78 1917 1919 O
premenopausal 79 92 1920 1933 O
women 93 98 1934 1939 B-gender

Patients 0 8 1940 1948 O
must 9 13 1949 1953 O
be 14 16 1954 1956 O
able 17 21 1957 1961 O
to 22 24 1962 1964 O
swallow 25 32 1965 1972 O
and 33 36 1973 1976 O
retain 37 43 1977 1983 O
oral 44 48 1984 1988 B-treatment
medication 49 59 1989 1999 I-treatment
and 60 63 2000 2003 O
must 64 68 2004 2008 O
not 69 72 2009 2012 O
have 73 77 2013 2017 O
any 78 81 2018 2021 O
clinically 82 92 2022 2032 O
significant 93 104 2033 2044 O
gastrointestinal 105 121 2045 2061 B-chronic_disease
abnormalities 122 135 2062 2075 I-chronic_disease
that 136 140 2076 2080 O
may 141 144 2081 2084 O
alter 145 150 2085 2090 O
absorption 151 161 2091 2101 O
such 162 166 2102 2106 O
as 167 169 2107 2109 O
malabsorption 170 183 2110 2123 B-chronic_disease
syndrome 184 192 2124 2132 I-chronic_disease
or 193 195 2133 2135 O
major 196 201 2136 2141 O
resection 202 211 2142 2151 B-treatment
of 212 214 2152 2154 I-treatment
the 215 218 2155 2158 I-treatment
stomach 219 226 2159 2166 I-treatment
or 227 229 2167 2169 I-treatment
bowels 230 236 2170 2176 I-treatment

Patients 0 8 2177 2185 O
must 9 13 2186 2190 O
be 14 16 2191 2193 O
at 17 19 2194 2196 O
least 20 25 2197 2202 O
18 26 28 2203 2205 B-lower_bound
years 29 34 2206 2211 I-lower_bound
of 35 37 2212 2214 O
age 38 41 2215 2218 B-age

Patients 0 8 2219 2227 O
must 9 13 2228 2232 O
have 14 18 2233 2237 O
an 19 21 2238 2240 O
ECOG 22 26 2241 2245 B-clinical_variable
performance 27 38 2246 2257 I-clinical_variable
status 39 45 2258 2264 I-clinical_variable
of 46 48 2265 2267 O
0 49 50 2268 2269 B-lower_bound
or 51 53 2270 2272 O
1 54 55 2273 2274 B-upper_bound

Patients 0 8 2275 2283 O
must 9 13 2284 2288 O
have 14 18 2289 2293 O
discontinued 19 31 2294 2306 O
active 32 38 2307 2313 O
immunotherapy 39 52 2314 2327 B-treatment
( 53 54 2328 2329 O
IL-2 54 58 2329 2333 B-treatment
, 58 59 2333 2334 O
interferon 60 70 2335 2345 B-treatment
, 70 71 2345 2346 O
CTLA-4 72 78 2347 2353 B-treatment
, 78 79 2353 2354 O
etc 80 83 2355 2358 O
. 83 84 2358 2359 O
) 84 85 2359 2360 O
or 86 88 2361 2363 O
chemotherapy 89 101 2364 2376 B-treatment
at 102 104 2377 2379 O
least 105 110 2380 2385 O
4 111 112 2386 2387 B-lower_bound
weeks 113 118 2388 2393 I-lower_bound
prior 119 124 2394 2399 I-lower_bound
to 125 127 2400 2402 O
entering 128 136 2403 2411 O
the 137 140 2412 2415 O
study 141 146 2416 2421 O
and 147 150 2422 2425 O
oral 151 155 2426 2430 B-treatment
targeted 156 164 2431 2439 I-treatment
therapy 165 172 2440 2447 I-treatment
at 173 175 2448 2450 O
least 176 181 2451 2456 O
2 182 183 2457 2458 B-lower_bound
weeks 184 189 2459 2464 I-lower_bound
prior 190 195 2465 2470 I-lower_bound
to 196 198 2471 2473 O
entering 199 207 2474 2482 O
the 208 211 2483 2486 O
study 212 217 2487 2492 O

Patients 0 8 2493 2501 O
must 9 13 2502 2506 O
have 14 18 2507 2511 O
histologically 19 33 2512 2526 O
confirmed 34 43 2527 2536 O
diagnosis 44 53 2537 2546 O
of 54 56 2547 2549 O
Stage 57 62 2550 2555 B-cancer
IV 63 65 2556 2558 I-cancer
metastatic 66 76 2559 2569 I-cancer
melanoma 77 85 2570 2578 I-cancer
positive 86 94 2579 2587 O
for 95 98 2588 2591 O
BRAF 99 103 2592 2596 O
V600E 104 109 2597 2602 O
or 110 112 2603 2605 O
V600 113 117 2606 2610 O
K 117 118 2610 2611 O
by 119 121 2612 2614 O
a 122 123 2615 2616 O
CLIA 124 128 2617 2621 B-treatment
approved 129 137 2622 2630 I-treatment
assay 138 143 2631 2636 I-treatment

Patients 0 8 2637 2645 O
must 9 13 2646 2650 O
not 14 17 2651 2654 O
receive 18 25 2655 2662 O
any 26 29 2663 2666 O
other 30 35 2667 2672 O
investigational 36 51 2673 2688 B-treatment
anticancer 52 62 2689 2699 I-treatment
therapy 63 70 2700 2707 I-treatment
during 71 77 2708 2714 O
the 78 81 2715 2718 O
period 82 88 2719 2725 O
on 89 91 2726 2728 O
study 92 97 2729 2734 O
or 98 100 2735 2737 O
the 101 104 2738 2741 O
four 105 109 2742 2746 B-lower_bound
weeks 110 115 2747 2752 I-lower_bound
prior 116 121 2753 2758 I-lower_bound
to 122 124 2759 2761 O
entry 125 130 2762 2767 O

Patients 0 8 2768 2776 O
receiving 9 18 2777 2786 O
concurrent 19 29 2787 2797 B-treatment
therapy 30 37 2798 2805 I-treatment
for 38 41 2806 2809 O
their 42 47 2810 2815 O
tumor 48 53 2816 2821 B-cancer
( 54 55 2822 2823 O
i.e. 55 59 2823 2827 O
chemotherapeutics 60 77 2828 2845 B-treatment
or 78 80 2846 2848 O
investigational 81 96 2849 2864 B-treatment
agents 97 103 2865 2871 I-treatment
) 103 104 2871 2872 O

Patients 0 8 2873 2881 O
receiving 9 18 2882 2891 O
cytochrome 19 29 2892 2902 B-treatment
P450 30 34 2903 2907 I-treatment
enzyme 35 41 2908 2914 I-treatment
- 41 42 2914 2915 I-treatment
inducing 42 50 2915 2923 I-treatment
anticonvulsant 51 65 2924 2938 I-treatment
drugs 66 71 2939 2944 I-treatment
( 72 73 2945 2946 I-treatment
EIADs 73 78 2946 2951 I-treatment
) 78 79 2951 2952 I-treatment
( 80 81 2953 2954 O
i.e. 81 85 2954 2958 O
phenytoin 86 95 2959 2968 B-treatment
, 95 96 2968 2969 O
carbamazepine 97 110 2970 2983 B-treatment
, 110 111 2983 2984 O
Phenobarbital 112 125 2985 2998 B-treatment
, 125 126 2998 2999 O
primidone 127 136 3000 3009 B-treatment
or 137 139 3010 3012 O
oxcarbazepine 140 153 3013 3026 B-treatment
) 153 154 3026 3027 O
within 155 161 3028 3034 O
4 162 163 3035 3036 B-upper_bound
weeks 164 169 3037 3042 I-upper_bound
of 170 172 3043 3045 O
the 173 176 3046 3049 O
start 177 182 3050 3055 O
of 183 185 3056 3058 O
the 186 189 3059 3062 O
study 190 195 3063 3068 O
treatment 196 205 3069 3078 B-treatment

Patients 0 8 3079 3087 O
that 9 13 3088 3092 O
are 14 17 3093 3096 O
asymptomatic 18 30 3097 3109 O
on 31 33 3110 3112 O
low 34 37 3113 3116 B-treatment
dose 38 42 3117 3121 I-treatment
maintenance 43 54 3122 3133 I-treatment
hormone 55 62 3134 3141 I-treatment
replacement 63 74 3142 3153 I-treatment
delivered 75 84 3154 3163 O
at 85 87 3164 3166 O
a 88 89 3167 3168 O
stable 90 96 3169 3175 O
dose 97 101 3176 3180 O
for 102 105 3181 3184 O
prior 106 111 3185 3190 O
toxicities 112 122 3191 3201 O

Patients 0 8 3202 3210 O
who 9 12 3211 3214 O
are 13 16 3215 3218 O
known 17 22 3219 3224 O
to 23 25 3225 3227 O
be 26 28 3228 3230 O
experiencing 29 41 3231 3243 O
an 42 44 3244 3246 O
objective 45 54 3247 3256 O
partial 55 62 3257 3264 O
response 63 71 3265 3273 O
to 72 74 3274 3276 O
immunotherapy 75 88 3277 3290 B-treatment
at 89 91 3291 3293 O
the 92 95 3294 3297 O
time 96 100 3298 3302 O
of 101 103 3303 3305 O
study 104 109 3306 3311 O
enrollment 110 120 3312 3322 O

Patients 0 8 3323 3331 O
who 9 12 3332 3335 O
are 13 16 3336 3339 B-pregnancy
pregnant 17 25 3340 3348 I-pregnancy

Patients 0 8 3349 3357 O
with 9 13 3358 3362 O
a 14 15 3363 3364 O
previously 16 26 3365 3375 O
documented 27 37 3376 3386 O
retinal 38 45 3387 3394 B-chronic_disease
vein 46 50 3395 3399 I-chronic_disease
occlusion 51 60 3400 3409 I-chronic_disease

Patients 0 8 3410 3418 O
with 9 13 3419 3423 O
brain 14 19 3424 3429 B-cancer
metastases 20 30 3430 3440 I-cancer
treated 31 38 3441 3448 O
with 39 43 3449 3453 O
whole 44 49 3454 3459 B-treatment
brain 50 55 3460 3465 I-treatment
radiation 56 65 3466 3475 I-treatment
that 66 70 3476 3480 O
have 71 75 3481 3485 O
been 76 80 3486 3490 O
stable 81 87 3491 3497 O
for 88 91 3498 3501 O
2 92 93 3502 3503 B-upper_bound
months 94 100 3504 3510 I-upper_bound

Patients 0 8 3511 3519 O
with 9 13 3520 3524 O
intra 14 19 3525 3530 B-treatment
- 19 20 3530 3531 I-treatment
cardiac 20 27 3531 3538 I-treatment
defibrillators 28 42 3539 3553 I-treatment

Patients 0 8 3554 3562 O
with 9 13 3563 3567 O
known 14 19 3568 3573 O
serious 20 27 3574 3581 O
concurrent 28 38 3582 3592 O
infection 39 48 3593 3602 B-chronic_disease
or 49 51 3603 3605 O
medical 52 59 3606 3613 O
illness 60 67 3614 3621 O
, 67 68 3621 3622 O
including 69 78 3623 3632 O
psychiatric 79 90 3633 3644 B-chronic_disease
disorders 91 100 3645 3654 I-chronic_disease
, 100 101 3654 3655 O
which 102 107 3656 3661 O
would 108 113 3662 3667 O
jeopardize 114 124 3668 3678 O
the 125 128 3679 3682 O
ability 129 136 3683 3690 O
of 137 139 3691 3693 O
the 140 143 3694 3697 O
patient 144 151 3698 3705 O
to 152 154 3706 3708 O
receive 155 162 3709 3716 O
the 163 166 3717 3720 O
treatment 167 176 3721 3730 B-treatment
outlined 177 185 3731 3739 O
in 186 188 3740 3742 O
this 189 193 3743 3747 O
protocol 194 202 3748 3756 O
with 203 207 3757 3761 O
reasonable 208 218 3762 3772 O
safety 219 225 3773 3779 O

Subjects 0 8 3780 3788 O
with 9 13 3789 3793 O
a 14 15 3794 3795 O
history 16 23 3796 3803 O
of 24 26 3804 3806 O
completely 27 37 3807 3817 O
resected 38 46 3818 3826 O
non 47 50 3827 3830 B-cancer
- 50 51 3830 3831 I-cancer
melanoma 51 59 3831 3839 I-cancer
skin 60 64 3840 3844 I-cancer
cancer 65 71 3845 3851 I-cancer

Subjects 0 8 3852 3860 O
with 9 13 3861 3865 O
controlled 14 24 3866 3876 O
atrial 25 31 3877 3883 B-chronic_disease
fibrillation 32 44 3884 3896 I-chronic_disease
for 45 48 3897 3900 O
> 49 50 3901 3902 O
30 50 52 3902 3904 B-lower_bound
days 53 57 3905 3909 I-lower_bound
prior 58 63 3910 3915 I-lower_bound
to 64 66 3916 3918 O
randomization 67 80 3919 3932 O

Subjects 0 8 3933 3941 O
with 9 13 3942 3946 O
moderate 14 22 3947 3955 O
valvular 23 31 3956 3964 B-chronic_disease
thickening 32 42 3965 3975 I-chronic_disease

Women 0 5 3976 3981 B-gender
must 6 10 3982 3986 O
use 11 14 3987 3990 B-contraception_consent
an 15 17 3991 3993 I-contraception_consent
effective 18 27 3994 4003 I-contraception_consent
method 28 34 4004 4010 I-contraception_consent
of 35 37 4011 4013 I-contraception_consent
contraception 38 51 4014 4027 I-contraception_consent
from 52 56 4028 4032 O
14 57 59 4033 4035 B-upper_bound
days 60 64 4036 4040 I-upper_bound
prior 65 70 4041 4046 I-upper_bound
to 71 73 4047 4049 O
randomization 74 87 4050 4063 O
, 87 88 4063 4064 O
throughout 89 99 4065 4075 O
the 100 103 4076 4079 O
treatment 104 113 4080 4089 B-treatment
period 114 120 4090 4096 O
, 120 121 4096 4097 O
and 122 125 4098 4101 O
for 126 129 4102 4105 O
at 130 132 4106 4108 O
least 133 138 4109 4114 O
6 139 140 4115 4116 B-lower_bound
months 141 147 4117 4123 I-lower_bound
after 148 153 4124 4129 I-lower_bound
the 154 157 4130 4133 O
last 158 162 4134 4138 O
dose 163 167 4139 4143 O
of 168 170 4144 4146 O
study 171 176 4147 4152 B-treatment
treatment 177 186 4153 4162 I-treatment
as 187 189 4163 4165 O
directed 190 198 4166 4174 O
by 199 201 4175 4177 O
their 202 207 4178 4183 O
physician 208 217 4184 4193 O
. 217 218 4193 4194 O
Effective 219 228 4195 4204 O
methods 229 236 4205 4212 O
of 237 239 4213 4215 O
contraception 240 253 4216 4229 O
are 254 257 4230 4233 O
defined 258 265 4234 4241 O
as 266 268 4242 4244 O
those 269 274 4245 4250 O
which 275 280 4251 4256 O
result 281 287 4257 4263 O
in 288 290 4264 4266 O
a 291 292 4267 4268 O
low 293 296 4269 4272 O
failure 297 304 4273 4280 O
rate 305 309 4281 4285 O
( 310 311 4286 4287 O
i.e. 311 315 4287 4291 O
, 315 316 4291 4292 O
less 317 321 4293 4297 O
than 322 326 4298 4302 O
1 327 328 4303 4304 B-upper_bound
% 328 329 4304 4305 I-upper_bound
per 330 333 4306 4309 O
year 334 338 4310 4314 O
) 338 339 4314 4315 O
when 340 344 4316 4320 O
used 345 349 4321 4325 O
consistently 350 362 4326 4338 O
and 363 366 4339 4342 O
correctly 367 376 4343 4352 O
( 377 378 4353 4354 O
for 378 381 4354 4357 O
example 382 389 4358 4365 O
implants 390 398 4366 4374 B-contraception_consent
, 398 399 4374 4375 O
injectables 400 411 4376 4387 B-contraception_consent
, 411 412 4387 4388 O
or 413 415 4389 4391 O
intra 416 421 4392 4397 B-contraception_consent
- 421 422 4397 4398 I-contraception_consent
uterine 422 429 4398 4405 I-contraception_consent
devices 430 437 4406 4413 I-contraception_consent
) 437 438 4413 4414 O
. 438 439 4414 4415 O
At 440 442 4416 4418 O
the 443 446 4419 4422 O
discretion 447 457 4423 4433 O
of 458 460 4434 4436 O
the 461 464 4437 4440 O
investigator 465 477 4441 4453 O
, 477 478 4453 4454 O
acceptable 479 489 4455 4465 O
methods 490 497 4466 4473 O
of 498 500 4474 4476 O
contraception 501 514 4477 4490 O
may 515 518 4491 4494 O
include 519 526 4495 4502 O
total 527 532 4503 4508 O
abstinence 533 543 4509 4519 B-contraception_consent
in 544 546 4520 4522 O
cases 547 552 4523 4528 O
where 553 558 4529 4534 O
the 559 562 4535 4538 O
lifestyle 563 572 4539 4548 O
of 573 575 4549 4551 O
the 576 579 4552 4555 O
patient 580 587 4556 4563 O
ensures 588 595 4564 4571 O
compliance 596 606 4572 4582 O
. 606 607 4582 4583 O
( 608 609 4584 4585 O
Periodic 609 617 4585 4593 B-contraception_consent
abstinence 618 628 4594 4604 I-contraception_consent
[ 629 630 4605 4606 O
e.g. 630 634 4606 4610 O
, 634 635 4610 4611 O
calendar 636 644 4612 4620 B-contraception_consent
, 644 645 4620 4621 O
ovulation 646 655 4622 4631 B-contraception_consent
, 655 656 4631 4632 O
symptothermal 657 670 4633 4646 B-contraception_consent
, 670 671 4646 4647 O
postovulation 672 685 4648 4661 B-contraception_consent
methods 686 693 4662 4669 I-contraception_consent
] 693 694 4669 4670 O
and 695 698 4671 4674 O
withdrawal 699 709 4675 4685 B-contraception_consent
are 710 713 4686 4689 O
not 714 717 4690 4693 O
acceptable 718 728 4694 4704 O
methods 729 736 4705 4712 O
of 737 739 4713 4715 O
contraception 740 753 4716 4729 O
. 753 754 4729 4730 O
) 754 755 4730 4731 O
Hormonal 756 764 4732 4740 B-contraception_consent
- 764 765 4740 4741 I-contraception_consent
based 765 770 4741 4746 I-contraception_consent
methods 771 778 4747 4754 I-contraception_consent
( 779 780 4755 4756 O
e.g. 780 784 4756 4760 O
, 784 785 4760 4761 O
oral 786 790 4762 4766 B-contraception_consent
contraceptives 791 805 4767 4781 I-contraception_consent
) 805 806 4781 4782 O
are 807 810 4783 4786 O
NOT 811 814 4787 4790 O
permitted 815 824 4791 4800 O
as 825 827 4801 4803 O
contraception 828 841 4804 4817 O
due 842 845 4818 4821 O
to 846 848 4822 4824 O
potential 849 858 4825 4834 O
drug 859 863 4835 4839 O
- 863 864 4839 4840 O
drug 864 868 4840 4844 O
interactions 869 881 4845 4857 O
with 882 886 4858 4862 O
dabrafenib 887 897 4863 4873 B-treatment

patients 0 8 4874 4882 O
with 9 13 4883 4887 O
brain 14 19 4888 4893 B-cancer
metastases 20 30 4894 4904 I-cancer
treated 31 38 4905 4912 O
with 39 43 4913 4917 O
gamma 44 49 4918 4923 B-treatment
knife 50 55 4924 4929 I-treatment
or 56 58 4930 4932 O
surgery 59 66 4933 4940 B-treatment
are 67 70 4941 4944 O
allowed 71 78 4945 4952 O
to 79 81 4953 4955 O
participate 82 93 4956 4967 O
after 94 99 4968 4973 B-upper_bound
3 100 101 4974 4975 I-upper_bound
weeks 102 107 4976 4981 I-upper_bound
have 108 112 4982 4986 O
elapsed 113 120 4987 4994 O
since 121 126 4995 5000 O
their 127 132 5001 5006 O
procedure 133 142 5007 5016 O
. 143 144 5017 5018 O
Demonstration 145 158 5019 5032 O
of 159 161 5033 5035 O
brain 162 167 5036 5041 O
stability 168 177 5042 5051 O
by 178 180 5052 5054 O
an 181 183 5055 5057 O
imaging 184 191 5058 5065 O
study 192 197 5066 5071 O
after 198 203 5072 5077 O
the 204 207 5078 5081 O
procedure 208 217 5082 5091 O
is 218 220 5092 5094 O
required 221 229 5095 5103 O
for 230 233 5104 5107 O
gamma 234 239 5108 5113 O
knife 240 245 5114 5119 O
or 246 248 5120 5122 O
CNS 249 252 5123 5126 B-treatment
surgery 253 260 5127 5134 I-treatment
patients 261 269 5135 5143 O

subjects 0 8 5144 5152 O
with 9 13 5153 5157 O
grade 14 19 5158 5163 O
1 20 21 5164 5165 O
abnormalities 22 35 5166 5179 O
[ 36 37 5180 5181 O
i.e. 37 41 5181 5185 O
, 41 42 5185 5186 O
mild 43 47 5187 5191 B-chronic_disease
regurgitation 48 61 5192 5205 I-chronic_disease
/ 61 62 5205 5206 O
stenosis 62 70 5206 5214 B-chronic_disease
] 70 71 5214 5215 O

subjects 0 8 5216 5224 O
with 9 13 5225 5229 O
indolent 14 22 5230 5238 O
second 23 29 5239 5245 O
malignancies 30 42 5246 5258 B-cancer

subjects 0 8 5259 5267 O
with 9 13 5268 5272 O
known 14 19 5273 5278 O
Gilbert 20 27 5279 5286 B-chronic_disease
's 27 29 5286 5288 I-chronic_disease
syndrome 30 38 5289 5297 I-chronic_disease

subjects 0 8 5298 5306 O
with 9 13 5307 5311 O
laboratory 14 24 5312 5322 O
evidence 25 33 5323 5331 O
of 34 36 5332 5334 O
cleared 37 44 5335 5342 O
HBV 45 48 5343 5346 B-chronic_disease
and/or 49 55 5347 5353 O
HCV 56 59 5354 5357 B-chronic_disease

